Enzo Biochem, headquartered in Farmingdale, has agreed to sell the assets of its clinical laboratory division to Labcorp, headquartered in Burlington, North Carolina. Enzo is selling the division for ...

VANCOUVER, British Columbia, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) is pleased to announce that the clinical trial, for novel anti-aging ...

Enzo Biochem has completed the previously announced transaction to sell substantially all of the assets located in the New York metropolitan region used in the operation of Enzo Clinical Labs to ...

Xsensio SA, a Swiss deep-tech company pioneering near real-time continuous biochemical monitoring, today announced the ...

Significant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY, March 16, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (ENZ) announced today that it has ...

Xsensio announced that it closed a $7 million oversubscribed Series A financing round to support its patient monitoring ...

VANCOUVER, BC, Oct. 13, 2020 /CNW/ - Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (US-OTC: SRBCF) ("Sirona") is pleased to announce that it has signed an agreement with a top 10 global pharmaceutical ...

Tests that look at changes in biochemistry have an important application in medicine, including point-of-care cardiac testing and monitoring heart failure. Biochemical tests can also be used to ...